REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 81 filers reported holding REATA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $42,459,000 | +1.4% | 300,000 | -28.6% | 0.75% | -14.3% |
| Q1 2021 | $41,874,000 | +5.9% | 420,000 | +31.2% | 0.88% | +12.5% |
| Q4 2020 | $39,558,000 | -9.4% | 320,000 | -28.6% | 0.78% | -26.4% |
| Q3 2020 | $43,644,000 | +6.9% | 448,000 | +71.1% | 1.06% | -10.6% |
| Q2 2020 | $40,841,000 | +53.9% | 261,765 | +42.4% | 1.19% | +41.2% |
| Q1 2020 | $26,539,000 | +29.8% | 183,865 | +83.9% | 0.84% | +29.1% |
| Q4 2019 | $20,443,000 | +29.2% | 100,000 | -49.2% | 0.65% | +1.1% |
| Q3 2019 | $15,817,000 | -14.9% | 197,000 | 0.0% | 0.64% | -3.4% |
| Q2 2019 | $18,587,000 | -40.3% | 197,000 | -45.9% | 0.67% | -44.0% |
| Q1 2019 | $31,111,000 | +52.4% | 364,000 | 0.0% | 1.19% | +46.0% |
| Q4 2018 | $20,420,000 | -15.0% | 364,000 | +23.8% | 0.82% | -5.1% |
| Q3 2018 | $24,037,000 | +12.8% | 294,000 | -51.8% | 0.86% | +15.0% |
| Q2 2018 | $21,316,000 | +166.5% | 609,554 | +56.3% | 0.75% | +170.4% |
| Q1 2018 | $7,999,000 | -27.6% | 390,000 | 0.0% | 0.28% | -36.3% |
| Q4 2017 | $11,045,000 | +86.9% | 390,000 | +105.3% | 0.44% | +63.5% |
| Q3 2017 | $5,909,000 | – | 190,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
| Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
| First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
| Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
| MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
| Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
| Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
| Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
| KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
| Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |